Innovative alternatives in the surgical management of glaucoma with cataract surgery.
Introduction: Glaucoma is the leading cause of irremediable blindness worldwide. The prevalence of glaucoma will continue to increase with the increased ageing of the global population. The only way to reduce the progression of vision loss due to glaucoma is to control the level of intraocular press...
| Published in: | Expert Review of Ophthalmology Vol. 12; no. 5; pp. 403 - 420 |
|---|---|
| Main Authors: | , , , , , |
| Format: | review tables/charts Journal Article |
| Published: |
Taylor & Francis Ltd
Oct2017
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=125457353&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 125457353 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17469899 3CML jtl: Expert Review of Ophthalmology issn: 17469899 maglogo: N pubinfo: dt: Oct2017 vid: 12 iid: 5 pid: 377 pub: Taylor & Francis Ltd place: Philadelphia, Pennsylvania artinfo: ui: 125457353 125457353 125457353 10.1080/17469899.2017.1362335 125457353 ppf: 403 ppct: 17 formats: tig: atl: Innovative alternatives in the surgical management of glaucoma with cataract surgery. aug: au: Ianchulev, Tsontcho Ahmed, Iqbal I. K. Stamper, Robert L. Chang, David F. Samuelson, Thomas W. Lindstrom, Richard L. affil: Department of Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, NY, U.S.A. sug: subj: Glaucoma Prevention and Control Intraocular Pressure Surgery, Operative Trends Trabeculectomy Medication Compliance Medication Errors Adverse Drug Event Health Care Costs ab: Introduction: Glaucoma is the leading cause of irremediable blindness worldwide. The prevalence of glaucoma will continue to increase with the increased ageing of the global population. The only way to reduce the progression of vision loss due to glaucoma is to control the level of intraocular pressure (IOP). IOP control initially depends upon pharmaceutical interventions. The efficacy of IOP-lowering medications is limited by poor patient compliance, incorrect medication administration, ocular side effects and cost. When IOP-lowering medications fail to halt the progression of glaucoma, surgical intervention, such as trabeculectomy or glaucoma drainage device surgery, is indicated, but neither has been found completely satisfactory. Surgical interventions have a significant risk of complications that result in decreased vision. Areas covered:This article summarizes the design and function, as well as reviewing the efficacy, of various innovative, highly safe, surgical approaches to the treatment of glaucoma. Expert opinion:Recent treatment innovations have taken advantage of the fact that many patients with mild-to-moderate glaucoma also have cataracts. Devices and procedures have been developed that are no more invasive than cataract surgery and that can be performed concurrently with cataract surgery. These IOP-lowering treatments have an excellent safety profile and minimize ocular tissue trauma. pubtype: Academic Journal doctype: review tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|